Abstract

The outcome for patients with diffuse large B-cell lymphomas improved dramatically in the last decade, and the opportunity for improving therapy for patients with peripheral T-cell lymphoma exists as we begin to study specific subtypes of the disease. It is entirely possible that patients with different genetic subtypes of diffuse large B-cell lymphoma will eventually require different treatments, and the same will be true for patients with subtypes of peripheral T-cell lymphoma. These possibilities will be the focus of clinical investigation over the next decade.

Original languageEnglish (US)
Pages (from-to)179-182
Number of pages4
JournalTransfusion and Apheresis Science
Volume44
Issue number2
DOIs
StatePublished - Apr 1 2011

Fingerprint

Lymphoma
Peripheral T-Cell Lymphoma
Lymphoma, Large B-Cell, Diffuse
Therapeutics

ASJC Scopus subject areas

  • Hematology

Cite this

Improving therapy for patients with aggressive lymphoma. / Armitage, James Olen.

In: Transfusion and Apheresis Science, Vol. 44, No. 2, 01.04.2011, p. 179-182.

Research output: Contribution to journalArticle

@article{b5d17b1b9ab34eb19a2070bd4d41db1e,
title = "Improving therapy for patients with aggressive lymphoma",
abstract = "The outcome for patients with diffuse large B-cell lymphomas improved dramatically in the last decade, and the opportunity for improving therapy for patients with peripheral T-cell lymphoma exists as we begin to study specific subtypes of the disease. It is entirely possible that patients with different genetic subtypes of diffuse large B-cell lymphoma will eventually require different treatments, and the same will be true for patients with subtypes of peripheral T-cell lymphoma. These possibilities will be the focus of clinical investigation over the next decade.",
author = "Armitage, {James Olen}",
year = "2011",
month = "4",
day = "1",
doi = "10.1016/j.transci.2011.01.013",
language = "English (US)",
volume = "44",
pages = "179--182",
journal = "Transfusion and Apheresis Science",
issn = "1473-0502",
publisher = "Elsevier Limited",
number = "2",

}

TY - JOUR

T1 - Improving therapy for patients with aggressive lymphoma

AU - Armitage, James Olen

PY - 2011/4/1

Y1 - 2011/4/1

N2 - The outcome for patients with diffuse large B-cell lymphomas improved dramatically in the last decade, and the opportunity for improving therapy for patients with peripheral T-cell lymphoma exists as we begin to study specific subtypes of the disease. It is entirely possible that patients with different genetic subtypes of diffuse large B-cell lymphoma will eventually require different treatments, and the same will be true for patients with subtypes of peripheral T-cell lymphoma. These possibilities will be the focus of clinical investigation over the next decade.

AB - The outcome for patients with diffuse large B-cell lymphomas improved dramatically in the last decade, and the opportunity for improving therapy for patients with peripheral T-cell lymphoma exists as we begin to study specific subtypes of the disease. It is entirely possible that patients with different genetic subtypes of diffuse large B-cell lymphoma will eventually require different treatments, and the same will be true for patients with subtypes of peripheral T-cell lymphoma. These possibilities will be the focus of clinical investigation over the next decade.

UR - http://www.scopus.com/inward/record.url?scp=79952627004&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79952627004&partnerID=8YFLogxK

U2 - 10.1016/j.transci.2011.01.013

DO - 10.1016/j.transci.2011.01.013

M3 - Article

C2 - 21345733

AN - SCOPUS:79952627004

VL - 44

SP - 179

EP - 182

JO - Transfusion and Apheresis Science

JF - Transfusion and Apheresis Science

SN - 1473-0502

IS - 2

ER -